|
National Clinical Care Commission (NCCC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NIDDK
|
The National Clinical Care Commission (NCCC) evaluates and provides recommendations on the coordination and leveraging of federal programs related to complex metabolic or autoimmune diseases that result from insulin-related issues and represent a significant disease burden in the United States, including complications due to such diseases. The HHS Assistant Secretary for Health (ASH) provides guidance and oversight for the Commission’s function and activities. The Office of Disease Prevention and Health Promotion (ODPHP) will provide management and support services for the Commission’s activities. The NCCC conducted its activities through October 2021 and submitted its final report of all findings and recommendations to the HHS Secretary and Congress.
|
|
National Clinical Trials Network (NCTN) Scientific Steering Committees (SSCs)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NCI
|
Scientific Steering Committees (SSCs) are composed of leading cancer experts and advocates from outside the Institute as well as NCI senior investigators who meet regularly to: (1) increase the transparency and openness of the trial design and prioritization process; (2) enhance patient advocate and community oncologist involvement in clinical trial design and prioritization; (3) convene Clinical Trial Planning Meetings to identify critical questions, unmet needs, and prioritize key strategies.
|
|
National Coalition for Oversight of Assisted Reproductive Technologies (NCOART)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NICHD
|
The National Coalition for Oversight of Assisted Reproductive Technologies (NCOART) has become a successful forum for discussion of issues by organizations involved in the assisted reproductive technologies (ART) in the United States.
|
|
National Collaborative on Childhood Obesity Research (NCCOR)
|
Research Initiative
|
CDC
|
NICHD, NCI, NHLBI, NIDDK, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP
|
The mission of the National Collaborative on Childhood Obesity Research is to improve the efficiency, effectiveness, and application of childhood obesity research, and to halt -- and reverse -- childhood obesity through enhanced coordination and collaboration.
|
|
National COVID Cohort Collaborative (N3C)
|
Research Initiative
|
FDA, ASPR, CMS
|
NCATS, NIGMS
|
The N3C is a partnership among the NCATS-supported Clinical and Translational Science Awards (CTSA) Program hubs, the National Center for Data to Health (CD2H), and NIGMS-supported Institutional Development Award Networks for Clinical and Translational Research (IDeA-CTR), to provide clinical data in close to real time to improve our knowledge of COVID-19 and potential treatment strategies. Collaborators will contribute and use COVID-19 clinical data to answer critical research questions to address the pandemic. As the largest limited dataset in US history with more than 11 Million participants (https://covid.cd2h.org/), the N3C initiative has demonstrated that it is possible to conduct science/learning healthcare across a large network, share and harmonize sensitive clinical data across modalities at a national scale and to realize the promise of precision medicine.The N3C effort is centered on the following:Establishing a secure data repository (the N3C Data Enclave) for studying COVID-19-related data.Receiving existing patient data derived from electronic health records (EHRs) provided by participating U.S. health care sites.Providing operational support for researchers using the N3C Data Enclave to navigate in the N3C platform and collaborate on COVID-19 research.Ensuring research using the N3C Data Enclave follows the rules and expectations of NCATS and its partners to keep the data secure and protect patient privacy.
|
|
National Database for Antibiotic Resistant Organisms (NDARO)
|
Resource Development
|
CDC, FDA
|
NIAID, CC, FIC, NCATS, NCI, NHLBI, NIA, NIAAA, NIDA
|
The objective of this collaboration is to produce a collection of high-quality genome sequences from antibiotic-resistant strains and to create and maintain a publicly accessible database -- National Database for antibiotic resistance (AR), developed and housed at the National Center for Biotechnology Information of the National Library of Medicine (NLM).
|
|
National Death Index Linkage Collaboration (NIH-NDI Agreement)
|
Resource Development
|
CDC
|
OD/DPCPSI/OBSSR, OD/IMOD
|
Beginning January 1, 2020, through an agreement between the National Institutes of Health (NIH) and the Centers for Disease Control (CDC) National Center for Health Statistics, (NCHS), NIH began reimbursing the NCHS National Death Index (NDI) for the costs of NIH-supported investigators to link their research databases with the NDI for the research aims supported by the NIH. "NIH-supported investigators" refers to extramural investigators actively funded by the NIH, contract investigators working under an active contract with the NIH, and intramural researchers employed by the NIH. These NIH-supported investigators can link their research data to the National Death Index (NDI) at no cost to the NIH supported investigator. NIH-supported investigators will continue to submit applications for NDI linkage as per current NDI procedures, including NDI review and approval. This agreement applies only to NIH-supported investigators who are actively funded by the NIH to conduct research that requires NDI linkage. To be covered under this agreement, the NIH-supported investigator must be the owner or steward of the research data to be linked to the NDI datafile, and subject to limitations in linkages as identified in the agreement. As a part of the NIH/NCHS agreement, NCHS will be implementing an enhanced online application and will increase the frequency of NDI releases to quarterly. NDI allows fully deidentified (public access) research datasets with NDI-linked data to be shared without further NDI approval. Potentially re-identifiable datasets also may be shared without further NDI approval provided the research dataset is not transferred from one investigator to another but instead shared via a data enclave provided that the investigator obtained approval in the original NDI application to share the data via an enclave. An investigator also may share potentially re-identifiable NDI-linked research datasets with a data repository without further NDI approval provided the data repository shares the dataset on behalf of the investigator bound to the same constraints as the investigator (i.e., shared only if the dataset is fully-deidentified or shared only via a data enclave if potentially re-identifiable). During the period of this agreement, NDI will attempt to negotiate with the 57 vital registration jurisdictions to allow further data sharing flexibility without NDI approval.
|
|
National Death Index Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD, CC, NCATS, NCI, NHLBI, NIA, NIAID, NIDA, NIMH, OD/DPCPSI/OBSSR
|
The National Death Index (NDI) is a centralized database of death record information on file in state vital statistics offices. Working with these state offices, the National Center for Health Statistics (NCHS) established the NDI as a resource to aid epidemiologists and other health and medical investigators with their mortality ascertainment activities. The National Death Index Working Group brings together federal and non-federal demographic experts to improve the quality, comprehensiveness, and utility of the National Death Index.
|
|
National Emerging Contaminant Research Initiative
|
Research Initiative
|
CDC, ATSDR, FDA
|
NIEHS
|
The National Emerging Contaminants Research Initiative (NECRI) organizes the contaminants of emerging concern (CEC) research into five strategic goals and provides guidance for an implementation plan that outlines steps to achieve the strategic goals and metrics to track progress. While Drinking Water (DW) is the medium of focus for the NECRI, it is recognized that CECs exist in multiple media that may be relevant for addressing public and environmental health needs
|
|
National Family Health History Group
|
Public Education Campaign
|
CDC
|
NHGRI, CC, OD/OSP
|
Federal, state, and other stakeholders focus on increasing awareness of the value of family health history in managing health risks. National Family History Day is designated by the Surgeon General for increasing awareness of the above. Members of this group coordinate public communications and resource development.
|